22, May 2026
India’s First CAR T-Cell Therapy Shows Durable Results: Two-Year Remission Achieved in Blood Cancer Patients
Bengaluru, May 22: In a major milestone in Indian oncology care, Immuneel Therapeutics’ Made-In-India CAR T-cell therapy has delivered the country’s first known long-term remission in patients with aggressive blood cancers. Seven patients treated in 2022 have now surpassed two years of progression-free survival (PFS), a first for any made-in-India CAR T-cell therapy. This achievement reinforces the durability of Immuneel’s approach and its potential to transform outcomes for patients with aggressive blood cancers.
The CAR T-cell therapy, known as Varnimcabtagene autoleucel (IMN-003A), under Immuneel’s IMAGINE Phase 2 clinical trial, aimed at treating adult patients with relapsed or refractory CD19-positive B-cell Non-Hodgkin Lymphoma (B-NHL) which is among the most aggressive forms of blood cancer, and many patients do not respond to standard therapies. In India, access to next-generation treatments like CAR T-cell therapy has been limited by cost and infrastructure, until now.
The encouraging results of the therapy recorded an 83% overall response rate (ORR) at Day 90 and a 50% ORR at Day 365, with a complete response rate of 83%, placing it among the highest reported outcomes in Indian clinical benchmarks for CAR T-cell therapies. The therapy has now been administered to more than 100 patients in India, marking Immuneel’s successful scale-up in delivering this complex therapy with consistent outcomes and a favorable safety profile. The data is backed up by 22+ presentations and publications at global platform along with original article publication in Blood-Immunology & Cellular Therapy.
Ms. Kiran Mazumdar-Shaw, Board Director & Co-Founder, Immuneel Therapeutics said, “Immuneel was founded with a clear mission to make advanced, life-saving cancer therapies accessible and affordable for patients in India. Seeing our Made-in-India CAR T therapy deliver durable remission outcomes across more than 100 patients; with several patients remaining in remission beyond two years, is a powerful validation of that mission. These encouraging long-term real-world outcomes demonstrate that innovation rooted in India can meet global benchmarks while addressing local healthcare needs at scale. As the clinical evidence continues to mature, Immuneel remains committed to strengthening India’s position in next-generation, transformative cancer therapies.”
Mr. Amit Mookim, Board Director & CEO, Immuneel Therapeutics, added, “This achievement is not just a clinical validation, but a strategic proof point of what’s possible when world-class science is built for India and beyond, in India. Crossing the two-year progression-free survival mark with multiple patients demonstrates that India can lead in delivering durable, next-generation therapies. At Immuneel, our focus remains on scaling access, deepening impact, and continuing to redefine what cancer care can look like for patients and families in India and beyond India.”
Globally, CAR T therapies are considered revolutionary but are often expensive and logistically challenging. Immuneel’s effort marks a turning point in making these advanced treatments accessible to Indian patients, particularly those who have exhausted other options.
Key Clinical Highlights:
• India’s Longest-Known CAR T Therapy Survivors: Seven patients enrolled in the Phase 2 IMAGINE trial have crossed the two-year PFS milestone, a first for any CAR T therapy in India, underscoring durable remission and the potential for improved long-term survival
• Strong and Sustained Response Rates: IMN-003A (clinical trial) showed an 83% ORR at Day 90, a 50% ORR at Day 365, and a Complete Response rate of 83%, setting new standards in treatment for relapsed/refractory CD19+ B-NHL
• 1000-Patients Milestone: Therapy has been successfully administered to more than 100 patients post commercialization across leading Indian hospitals, demonstrating consistent clinical outcomes, favorable safety profile, and Immuneel’s ability to scale complex cell therapy delivery nationally
• Backed by DBT-BIRAC Grant: The IMAGINE Phase 2 trial was supported by BIRAC (Biotechnology Industry Research Assistance Council) under the Department of Biotechnology’s BIPP scheme, underscoring national recognition of its scientific merit
- 0
- By Neel Achary
21, May 2026
SimonMed leads largest global study of AI in X-ray, analyzing 258,373 exams across 26 countries
SCOTTSDALE, AZ. May 21, 2026 — A landmark, peer-reviewed global study representing the largest published evaluation of artificial intelligence in X-ray imaging has been published in Radiography, analyzing 258,373 X-rays from 100 medical centers across 26 countries and five continents. The study was led by Dr. Sean Raj, Chief Medical Officer and Chief Innovation Officer at SimonMed, who served as senior author.
SimonMed, one of the largest outpatient imaging providers in the United States, contributed U.S. clinical data and played a central role in the study’s design, execution, and analysis, reinforcing its leadership in the clinical validation of artificial intelligence in radiology.
The study evaluated all four components of the Rayvolve® AI Suite as a unified clinical platform under real-world conditions, with no exclusions based on image quality or acquisition protocol. The system demonstrated high diagnostic performance across multiple use cases, including musculoskeletal trauma, chest imaging, automated measurements, and bone age assessment. AZtrauma achieved an AUC of 98.3% (sensitivity: 97.4%, specificity: 96.4%) across 195,706 musculoskeletal examinations. AZchest demonstrated an AUC of 97.8% (sensitivity: 96.7%, specificity: 87.9%) across 61,418 chest radiographs covering six pathology categories. AZmeasure and AZboneage delivered measurement precision within 1.83 degrees for angles, 1.1 mm for lengths, and a bone age estimation error of approximately six months.
Performance remained consistent across pathologies, anatomies, patient demographics, and global care settings, with all 258,373 images processed without a single technical failure, highlighting both the robustness and scalability of AI in real-world clinical environments.
SimonMed’s contribution to the study builds on a partnership that has deepened since 2023, when SimonMed selected AZmed as its AI partner for X-ray diagnostics following an independent evaluation across its outpatient network. That initial deployment demonstrated a 6x reduction in turnaround time for fracture cases and 98.5% sensitivity across SimonMed centers. SimonMed subsequently provided the clinical data that supported AZmed’s 2024 FDA 510(k) clearance for pediatric fracture detection. The inclusion of SimonMed’s U.S. imaging data in this 26-country study extends the collaboration from operational deployment and regulatory contribution to large-scale, independently published clinical evidence.
“Validating a complete AI suite at this scale, across 100 centers in 26 countries, establishes a new standard for clinical evidence in radiology AI,” said Julien Vidal, CEO of AZmed. “SimonMed’s contribution at every stage of this journey, from early U.S. deployment through FDA clearance and now the largest published X-ray AI study, reflects the kind of clinical partnership that advances the entire field.”
“This study represents a defining moment for AI in medical imaging,” said Dr. Sean Raj, Chief Medical Officer and Chief Innovation Officer at SimonMed. “We are proud to have led a global effort that not only validates AI performance at an unprecedented scale, but also reinforces the importance of rigorous, real-world clinical evidence. We are committed to continue our founding mission – to deliver high quality, accessible care at scale while measurably improving diagnostic quality for our radiologists and the patients they serve.”
The study is available in Radiography.
21, May 2026
The Growing Role of Water Testing Labs in Ensuring Safe and Sustainable Water Quality
With increasing concerns over water pollution, industrial contamination, and public health risks, the role of water testing laboratories has become more important than ever. Water quality testing helps identify harmful contaminants, assess safety standards, and ensure that water is suitable for drinking, industrial use, agriculture, and environmental applications. As urbanization and industrial activities continue to expand, regular water monitoring has become a crucial step in protecting both human health and natural ecosystems.
Choosing the best water testing lab is essential for accurate analysis and reliable results. Professional laboratories use advanced scientific techniques to test critical parameters such as pH, turbidity, heavy metals, microbial contamination, total dissolved solids (TDS), and chemical pollutants. These services help industries, households, and regulatory bodies make informed decisions about water safety while ensuring compliance with environmental and public health standards.

Water testing laboratories play a vital role in detecting contaminants at an early stage, preventing potential health hazards before they escalate. Contaminated water can contain harmful substances such as lead, arsenic, pesticides, bacteria, viruses, and industrial chemicals that may lead to serious diseases and long-term health complications. Through routine testing and laboratory-based analysis, these risks can be identified and controlled effectively.
In industrial sectors, water testing labs support quality control, wastewater treatment monitoring, and regulatory compliance. Industries rely on laboratory analysis to maintain process efficiency, prevent environmental pollution, and meet discharge standards set by authorities. Similarly, municipal bodies use water testing services to ensure safe drinking water distribution and maintain public sanitation systems.
Modern water testing laboratories also use advanced technologies such as ICP-MS, GC-MS, microbiological analysis, and real-time monitoring systems to provide highly accurate and timely results. These scientific methods improve contamination detection and help create data-driven water management strategies.
As water quality challenges continue to grow worldwide, water testing laboratories remain a critical pillar of public health, environmental protection, and sustainable resource management. Their role in ensuring safe water access, preventing contamination, and supporting regulatory compliance makes them indispensable in building a healthier and more sustainable future.
21, May 2026
WellSpan Health Reports 66% Reduction in Workplace Violence Following Systemwide Safety Initiative with Canopy
PALO ALTO, CA. May 21 – Canopy, a connected safety platform for hospitals and health systems focused on protecting nurses and staff, announced a new case study today with Pennsylvania health system WellSpan Health, showing measurable shifts after rolling out a systemwide workplace violence prevention strategy supported by Canopy’s technology.
According to the joint case study, WellSpan Health saw a 66% reduction in workplace violence-related DART (Days Away, Restricted or Transferred) injuries within a year of implementation. The initiative centralized public safety operations and emergency response protocols into a unified system, supported by wearable and RTLS technology that allows staff to quickly signal for help during escalating situations.
“One of WellSpan’s organizational goals is zero harm, not just in workplace violence but across all injuries,” said Bill White, Vice President of Public Safety at WellSpan Health. “We have an obligation to provide a safe environment for anyone who enters our facilities,” White noted that before Canopy, alerts were often delayed, and staff didn’t have a dependable way to quickly signal for help. “That’s changed with Canopy,” he said. “Our team members now have immediate access to support at the push of a button, which helps us respond faster and makes them feel more supported in real time.”
WellSpan identified several operational gaps across its growing network of hospitals and care sites before launching the initiative. Emergency alerts varied by location, and staff often had to locate a phone or secondary device before requesting security support, which slowed response during critical moments. After implementing Canopy, WellSpan rolled out instant notifications, integrated the DASA (Dynamic Appraisal of Situational Aggression) framework, and enhanced data validation tools to improve response times and increase staff visibility during incidents.
Workplace violence in hospitals continues to be one of healthcare’s fastest-growing operational and workforce challenges. The WellSpan and Canopy report was released during National Nurses Month, highlighting this ongoing, yet underrecognized issue throughout U.S. health systems. WellSpan leaders noted that the initiative was designed to reduce physical incidents while also shifting the organization toward a more proactive safety model across departments and campuses.
“Healthcare organizations everywhere are looking for better ways to support and protect frontline staff,” said Shan Sinha, CEO of Canopy Works. “The kind of impact Canopy and WellSpan have achieved together is exactly what Canopy strives for: creating environments where staff can get help quickly, feel supported in high-stress situations, and focus on delivering care safely. We’re proud to partner with WellSpan in building a stronger culture of safety for healthcare workers every day.”
Healthcare workforce safety has become an increasingly important area of focus nationally as organizations seek new approaches to meet evolving expectations around workforce well-being and retention in clinical environments. Industry analysts and healthcare leaders have pointed to workplace safety as a key component of long-term workforce sustainability.
Canopy is creating a standardized process for emergency response and safety across its expanding network. With WellSpan as a strong example of success, Canopy continues to support healthcare organizations in building safer environments for nurses, staff, patients, and visitors.
21, May 2026
The Silent Cost of Postponing Oral Hygiene – Oral Health Analysis by Leading Health Expert Dr. Sonia Datta

Kolkata | May 21: While many individuals wait for an acute toothache to signal a problem, dental experts are highlighting a growing concern regarding the “silent” progression of oral health issues. Most dental complications, from cavities to gum disease, begin without immediate pain or visible symptoms, leading to a dangerous cycle of postponement. This delay often allows minor issues to transform into significant long-term damage before a patient even realizes a problem exists.
The hidden progression of neglect begins when hygiene is overlooked, allowing plaque to harden into tartar within a matter of days. Once tartar forms, it cannot be removed by standard brushing, creating a foundation for chronic inflammation, enamel erosion, and eventual tooth loss. Dentists point out that the biggest mistake is equating the absence of pain with the absence of a disease. By the time discomfort finally manifests, the condition has often advanced to a stage that requires complex, invasive, and costly intervention rather than simple preventive maintenance.
In response to these risks, there is a renewed focus on preventive care that integrates time-tested natural solutions with modern science. Ayurvedic ingredients such as clove and neem have long been recognized for their potent antibacterial and anti-inflammatory properties, which help control harmful bacteria and soothe gum tissue. Dabur Red Paste incorporates these traditional botanicals into a clinically tested daily formulation that carries the IDA Seal of Acceptance, providing a scientifically backed tool to combat plaque and prevent the onset of serious dental conditions.
Maintaining long-term oral health requires a shift from reactive treatment to proactive habits. Consistent brushing twice daily with a validated toothpaste like Dabur Red Paste, combined with daily flossing and reduced sugar intake, forms a critical defense against acid exposure and bacterial buildup. When these daily habits are supported by regular professional check-ups, oral diseases can be identified and managed in their earliest stages. Choosing a proactive regimen is the most effective way to protect one’s smile and avoid the inevitable physical and financial costs of dental neglect –Oral Health Analysis by Leading Health Expert Dr. Sonia Datta.
18, May 2026
SimonMed Launches Shield Program to Support Preventive Whole-Body MRI Access for Military, Veterans, and First Responders
SCOTTSDALE, AZ – May 18, 2026 – SimonMed, one of the largest outpatient imaging providers in the United States, today announced the launch of the SimonMed Shield Program, a permanent nationwide initiative designed to help military personnel, veterans, and first responders access proactive whole-body MRI screening at a reduced cost. Through the program, eligible individuals will receive 20% off any SimonMed Longevity whole-body MRI.
The SimonMed Shield Program is designed to help those who serve take a more proactive approach to their health through advanced, radiation-free imaging that can be designed to help identify potential health issues earlier and establish a meaningful clinical baseline.
Military personnel and first responders often work in physically and emotionally demanding environments where prioritizing personal health can take a back seat to service.
“Many veterans and first responders spend years focused on protecting others while putting their own health second,” said Dr. Sean Raj, Chief Medical Officer and Chief Innovation Officer at SimonMed. “The Shield Program is one way we can support them in taking a more proactive approach to their own health through advanced imaging designed to help identify potential concerns earlier.”
Beginning on Armed Forces Day, eligible patients can access the ongoing program benefit at SimonMed locations nationwide. No referral is required, HSA and FSA funds may be used and each whole-body MRI includes a 1:1 virtual clinical consultation to review findings and next steps. If additional evaluation is recommended, patients may also have access to follow-up imaging services across SimonMed’s nationwide network, including advanced MRI, CT, cardiac, women’s imaging, and bone health services—supporting a more seamless care journey. The Shield Program is available to veterans, active-duty military, reserve, and National Guard members, police officers, firefighters, EMTs, and paramedics.
SimonMed’s Longevity whole-body MRI evaluates 13+ organs and systems in a single, radiation-free exam, including the brain, spine, chest, abdomen, and pelvic organs. The scan may help identify potential abnormalities associated with conditions such as certain cancers, fatty liver disease, aneurysms, and musculoskeletal or spinal degeneration—often before symptoms appear.
The Shield Program reflects SimonMed’s broader commitment to expanding access to preventive imaging and supporting the long-term health of those who dedicate their lives to protecting and serving others. Eligible individuals can learn more or schedule an appointment at SimonMed.com/Shield.
18, May 2026
Understanding Hypertension’s Silent Impact on Heart Health
Jalandhar, May 18 : Most people associate a heart attack with a sudden, dramatic event. What receives far less attention is the years of quiet damage that precede it. Often functioning without any symptoms, hypertension works silently, putting additional pressure on the arteries. Over the years, that sustained pressure quietly restructures the heart in ways that can prove fatal. In India, this is not a distant risk. According to data from the National Family Health Survey (NFHS-5), roughly 24% of adult men and 21% of adult women live with hypertension. The numbers tell a story of a condition hiding in plain sight.

On the occasion of World Hypertension Day, Dr VP Sharma, Director and Senior Consultant Cardiology, Fortis Hospital Jalandhar shared expert insight on hypertension, risks of developing cardiac-health issues, symptoms, and treatment.
What Hypertension Does to the Heart
Blood pressure is simply the force blood exerts against artery walls as the heart pumps. Normal blood pressure sits below 120/80 mm Hg. Hypertension is defined as readings that consistently reach or exceed 130/80 mm Hg. In response, the heart pumps harder to push blood through the arteries. This heightens the risk of developing various cardiac-related issues, including:
•Left Ventricular Hypertrophy: The most direct cardiac consequence of this is left ventricular hypertrophy (LVH), in which the walls of the heart’s main pumping chamber become thickened. LVH is an important independent risk factor for diastolic heart failure and sudden cardiac death in hypertensive patients. • Arterial Stiffness: Prolonged high blood pressure also contributes to arterial stiffness, which is the loss of elasticity of the large blood vessels. This diminishes their capacity to absorb the pressure wave generated by each heartbeat.
•Atrial Fibrillation: An irregular heart rhythm that can put you at risk for stroke and other complications.
Symptoms to Watch Out For
Hypertension often shows no symptoms, earning it the title “silent killer”. However, very high blood pressure, often exceeding 180/120 mm Hg, can show possible symptoms like:
●Shortness of breath (Dyspnoea)
●Dizziness
●Blurred or tunnel vision
●Nose bleeds (Epistaxis)
●Confusion
How to Manage Hypertension
●Reduce common salt intake in your diet, as sodium can heighten blood pressure
●Add vegetables like spinach, broccoli and carrots to your meals
●Fruits like strawberries, raspberries and blueberries contain antioxidants that can reduce inflammation in the inner lining of the blood vessels
●Adding daily options like bananas, oranges, and avocados to your diet can provide potassium to help offset sodium’s effect
●Avoid consuming tobacco products as they are direct contributors to high blood pressure
●Limit alcohol consumption as it can raise blood pressure and worsen cardiovascular risks
●Maintain regular physical activity and try to lose weight
Regularly monitoring your blood pressure and making these lifestyle and dietary changes can significantly reduce the risks of developing cardiac issues.
14, May 2026
Manipal Hospital Bhubaneswar Strengthens Airway Management Training Through MANIPAL AIRCON 2026
Bhubaneswar, May 14, 2026: Manipal Hospital Bhubaneshwar successfully hosted the 3rd Edition of MANIPAL AIRCON 2026 at Bhubaneswar, bringing together leading anaesthesiologists, critical care specialists, and airway management experts for a comprehensive academic conference focused on perioperative excellence and advanced airway care.
The event witnessed enthusiastic participation from over 100 delegates including 25 distinguished faculties from various institutions , making it a vibrant platform for knowledge exchange and skill enhancement. The event was graced by Chief Guest Dr Jitamitra Mishra, President, Indian Society of Anaesthesiologists Bhubaneswar City Branch, in the presence of Dr. Saktimaya Mohapatra, Cluster Director (South East), Manipal Hospitals.

The conference was organised under the leadership of Chairperson Dr Swarnamayee Sathpathy, with Dr Sujata Priyadarshini serving as the Organising Secretary and Dr Bhagya Ranjan Jena leading the Scientific Committee. Their collective efforts played a pivotal role in curating a high-quality academic programme that blended evidence-based learning with practical clinical training.
The scientific programme featured six insightful lectures covering both Basic Airway Management and Difficult Airway Management, with discussions centred on practical approaches, patient safety, emergency preparedness, and recent advancements in airway care. The conference also emphasised experiential learning through eight highly interactive hands-on workshops designed to strengthen clinical expertise in managing routine and complex airway scenarios. Key workshop sessions included Advanced Airway Simulation, Fibreoptic Intubation Techniques, Video laryngoscopy, Emergency Cricothyrotomy, Difficult Airway Algorithms, Ultrasound-Guided Airway Assessment, Airway Management in Critical Care, and Paediatric Airway Management. The workshops enabled delegates to gain practical exposure under the guidance of experienced faculty members and industry experts.

Speaking on the occasion, Dr Jitamitra Mishra, President, Indian Society of Anaesthesiologists Bhubaneswar City Branch, said, “Continuous academic engagement and practical training are essential to strengthening airway management practices and enhancing perioperative patient safety. MANIPAL AIRCON 2026 has provided an excellent platform for healthcare professionals to exchange knowledge, sharpen clinical skills, and stay updated with evolving techniques and innovations in airway care.” Adding to this,
Dr Saktimaya Mohapatra, Cluster Director (South East), Manipal Hospitals said, “Airway management remains one of the most critical components of perioperative and emergency care. Conferences like MANIPAL AIRCON 2026 play an essential role in bridging academic learning with real-world clinical practice, ultimately improving patient outcomes and strengthening preparedness among healthcare professionals.” MANIPAL AIRCON 2026 further reinforced Manipal Hospital’s commitment to continuous medical education, multidisciplinary collaboration, and clinical excellence in anaesthesia and critical care. The conference also highlighted the institution’s focus on fostering advanced skill development and bringing contemporary global practices in airway management closer to healthcare professionals across the region.
14, May 2026
Apex Hospital in Borivali Brings Advanced Minimally Invasive Bunion Surgery to Mumbai’s Suburban Area
Mumbai, May 14: A major breakthrough in orthopaedic innovation has been achieved at Apex Hospital, Borivali with the successful performance of a fourth-generation minimally invasive Hallux Valgus correction surgery, introducing a highly advanced treatment option for patients suffering from painful bunion deformities. The cutting-edge procedure offers reduced pain, faster recovery, minimal scarring, and quicker return to mobility compared to conventional open surgeries.

The surgery was successfully performed at Apex Hospital, Borivali by Dr. Pratik Vishavadia, an Orthopaedic Foot and Ankle Specialist, using the advanced META technique Minimally-invasive Extra-articular Transverse metatarsal with Akin’s osteotomy using a specialised high-precision burr system. Unlike traditional bunion correction procedures that require large incisions and extensive soft tissue dissection, this next-generation technique is performed through multiple tiny stab incisions, significantly reducing tissue trauma and post-operative discomfort.
Speaking about the advancement, Dr. Pratik Vishavadia from Apex Hospital, Borivali said,
“Minimally invasive foot and ankle surgery is transforming the future of orthopaedic care. Advanced procedures such as META osteotomy enable us to correct complex bunion deformities while preserving surrounding soft tissues. Patients experience significantly less pain, minimal blood loss, faster rehabilitation, and earlier return to normal activities. This approach reflects the global shift toward patient-friendly orthopaedic solutions that prioritise both clinical excellence and quality of recovery.”
Hallux Valgus, commonly referred to as a bunion deformity, is a progressive condition affecting the great toe joint. It often leads to chronic pain, difficulty in wearing footwear, cosmetic deformity, imbalance while walking, and restricted mobility. Orthopaedic experts note that untreated bunions can gradually worsen over time, impacting overall gait mechanics and quality of life.
Globally, studies indicate that bunion deformities affect nearly one in four adults between the ages of 18 and 65, with prevalence rising sharply among women and elderly individuals. The increasing preference for minimally invasive orthopaedic procedures reflects growing patient awareness around shorter hospital stays, enhanced cosmetic outcomes, and accelerated recovery timelines.
The successful adoption of this fourth-generation minimally invasive technique further strengthens the position of Apex Hospital, Borivali as a centre for advanced orthopaedic and Foot & Ankle care in the region. Experts believe such innovations will play a crucial role in improving long-term functional outcomes, patient comfort, and rehabilitation standards in modern orthopaedics.
13, May 2026
Apex Group of Hospitals Celebrates International Nurses Day Across All Its Hospitals
Mumbai, May 13: Apex Group of Hospitals celebrated International Nurses Day with gratitude and pride across all its Mumbai hospitals, recognising the tireless dedication, compassion, and commitment of its nursing staff who continue to play a vital role in patient care and recovery. Celebrations across all Apex hospitals included special appreciation ceremonies, cultural activities, motivational sessions, and awards honouring exceptional nurses for their service and contribution to healthcare excellence.
Speaking on the occasion, the management of Apex Group of Hospitals said, “Nursing is the backbone of every hospital. Nurses are not only caregivers but also emotional support systems for patients and families during their most difficult moments. Their strength, empathy, and commitment form the foundation of quality healthcare.”
The event highlighted the critical role nurses play in ensuring patient safety, comfort, and recovery. From emergency care and operating theatres to intensive care units and general wards, nurses remain at the forefront of healthcare delivery every single day. Doctors, management teams, and hospital staff joined together to express their appreciation for the nursing fraternity. Several nurses who demonstrated outstanding dedication, leadership, and patient care were felicitated during the celebrations. Nurses play a vital role in India’s healthcare system by providing compassionate care, emotional support, and round-the-clock medical attention to patients. They are the backbone of hospitals, ensuring patient safety, recovery, and comfort at every stage of treatment. From emergency care to rural healthcare services, nurses work tirelessly with dedication and humanity. Their contribution strengthens the nation’s healthcare system and improves countless lives every day.
Apex Group of Hospitals consistently focuses on creating a supportive and growth-oriented environment for its nursing professionals through continuous training, skill development programs, and modern healthcare practices. International Nurses Day, celebrated globally on May 12, marks the birth anniversary of Florence Nightingale, the founder of modern nursing. The occasion serves as an opportunity to recognise the invaluable contribution of nurses to society and healthcare systems worldwide. Through this celebration, Apex Group of Hospitals reaffirmed its commitment to supporting and empowering nurses who continue to serve humanity with compassion, courage, and care.
